# Investigation of Efficacy and Safety of PPC-5650 to Experimental Induced Sensation and Pain in the Rectosigmoid

> **NCT01449487** · PHASE1 · COMPLETED · sponsor: **Aros Pharma ApS** · enrollment: 25 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** PPC-5650
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01449487
- **Lead sponsor:** Aros Pharma ApS
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2013-05
- **Final completion:** 2013-05
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2014-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01449487

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01449487, "Investigation of Efficacy and Safety of PPC-5650 to Experimental Induced Sensation and Pain in the Rectosigmoid". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01449487. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*